Jerome A. Yesavage

TL;DR: The findings support the concept of conformation-specific, cross-reactive antibodies that may protect against amyloidogenic toxic peptides and stimulating the production of such neuroprotective antibodies or passively administering them to the elderly population may provide a preventive measure toward AD.

TL;DR: The results revealed that SG may offer very useful tools for professionals involved in the care of patients suffering from ADRD, however, more interdisciplinary work should be done in order to create SG specifically targeting these populations.

TL;DR: The revised diagnostic criteria for apathy was developed in a two-step process and included researchers and health care professionals working on brain disorders and apathy, a representative of a regulatory body, and a representative the pharmaceutical industry.

TL;DR: Clinicians in 6 VA medical centers were surveyed in 1999 and 2001 regarding their use of various assessment and treatment procedures, and practices most consistent with guideline recommendations included psychoeducation, coping skills training, attention to trust issues, depression and substance use screening, and prescribing of SSRIs, anticonvulsants, and trazodone.